ZYME Zymeworks Inc

Price (delayed)

$36.25

Market cap

$1.67B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.8

Enterprise value

$1.4B

Highlights
The company's debt fell by 8% YoY and by 2.8% QoQ
Zymeworks's revenue has increased by 21% YoY but it has decreased by 20% from the previous quarter
Zymeworks's gross profit has increased by 21% YoY but it has decreased by 20% QoQ
The company's equity fell by 28% YoY and by 8% QoQ
Zymeworks's net income has decreased by 19% YoY and by 7% QoQ

Key stats

What are the main financial stats of ZYME
Market
Shares outstanding
46.17M
Market cap
$1.67B
Enterprise value
$1.4B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
4.43
Price to sales (P/S)
59.44
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
44.76
Earnings
Revenue
$31.33M
EBIT
-$193.43M
EBITDA
-$183.35M
Free cash flow
-$159.19M
Per share
EPS
-$3.8
Free cash flow per share
-$3.1
Book value per share
$8.17
Revenue per share
$0.61
TBVPS
$9.22
Balance sheet
Total assets
$490.06M
Total liabilities
$112.91M
Debt
$8.29M
Equity
$377.15M
Working capital
$362.52M
Liquidity
Debt to equity
0.02
Current ratio
6.16
Quick ratio
5.92
Net debt/EBITDA
1.48
Margins
EBITDA margin
-585.3%
Gross margin
100%
Net margin
-619.3%
Operating margin
-627.3%
Efficiency
Return on assets
-35.2%
Return on equity
-45.4%
Return on invested capital
-90.2%
Return on capital employed
-46.1%
Return on sales
-617.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ZYME stock price

How has the Zymeworks stock price performed over time
Intraday
-5.06%
1 week
-3.92%
1 month
20.39%
1 year
-1.84%
YTD
-23.3%
QTD
14.79%

Financial performance

How have Zymeworks's revenue and profit performed over time
Revenue
$31.33M
Gross profit
$31.33M
Operating income
-$196.52M
Net income
-$194.01M
Gross margin
100%
Net margin
-619.3%
The company's net margin fell by 34% QoQ
The operating margin has decreased by 30% from the previous quarter but it has increased by 6% YoY
Zymeworks's revenue has increased by 21% YoY but it has decreased by 20% from the previous quarter
Zymeworks's gross profit has increased by 21% YoY but it has decreased by 20% QoQ

Growth

What is Zymeworks's growth rate over time

Valuation

What is Zymeworks stock price valuation
P/E
N/A
P/B
4.43
P/S
59.44
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
44.76
ZYME's EPS is down by 6% since the previous quarter but it is up by 6% year-on-year
The company's equity fell by 28% YoY and by 8% QoQ
Zymeworks's revenue has increased by 21% YoY but it has decreased by 20% from the previous quarter
The stock's price to sales (P/S) is 11% less than its last 4 quarters average of 66.9

Efficiency

How efficient is Zymeworks business performance
ZYME's ROIC is down by 36% since the previous quarter but it is up by 6% year-on-year
ZYME's ROS is down by 34% since the previous quarter but it is up by 2.1% year-on-year
Zymeworks's return on equity has decreased by 17% QoQ
Zymeworks's ROA has decreased by 15% from the previous quarter

Dividends

What is ZYME's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ZYME.

Financial health

How did Zymeworks financials performed over time
Zymeworks's total assets has decreased by 23% YoY and by 9% QoQ
The company's current ratio rose by 16% QoQ but it fell by 11% YoY
The company's debt is 98% lower than its equity
The company's equity fell by 28% YoY and by 8% QoQ
The company's debt fell by 8% YoY and by 2.8% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.